Kevin Wei

2.3k total citations · 1 hit paper
6 papers, 1.7k citations indexed

About

Kevin Wei is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kevin Wei has authored 6 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Kevin Wei's work include Cancer, Hypoxia, and Metabolism (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Virus-based gene therapy research (1 paper). Kevin Wei is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Virus-based gene therapy research (1 paper). Kevin Wei collaborates with scholars based in United States and India. Kevin Wei's co-authors include Calvin J. Kuo, Mary Jean Sunshine, Yu Wang, K Wright, Thomas J. Schall, Dan R. Littman, Jennifer M. Burns, Anita Melikian, Zhenhua Miao and Mark E.T. Penfold and has published in prestigious journals such as Nature, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Kevin Wei

5 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

2006 1.0k citations Jennifer M. Burns, Yu Wang et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Kevin Wei

Since Specialization

Citations

This map shows the geographic impact of Kevin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Wei more than expected).

Fields of papers citing papers by Kevin Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Wei. The network helps show where Kevin Wei may publish in the future.

Co-authorship network of co-authors of Kevin Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Wei. A scholar is included among the top collaborators of Kevin Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Wei. Kevin Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes 2013 ·Nature Medicine ·Cullen M. Taniguchi, Elizabeth Finger, Adam J. Krieg, Colleen Wu, Anh N. Diep, Edward L. LaGory, Kevin Wei, Lisa McGinnis, Jenny Yuan, Calvin J. Kuo, Amato J. Giaccia	118
2	A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition - eScholarship 2013 ·Jacquelyn J. Maher, Kevin Wei, (unknown), (unknown), (unknown), SJ Wiegand, Kevan Anderson, (unknown), (unknown), Daih‐Huang Kuo, Jiuhong Yuan	0
3	AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer 2010 ·Cancer Research ·Erinn B. Rankin, Katherine C. Fuh, (unknown), Adam J. Krieg, Margaret Musser, Jenny Yuan, Kevin Wei, Calvin J. Kuo, Teri A. Longacre, Amato J. Giaccia	181
4	Endochondral ossification is required for haematopoietic stem-cell niche formation 2008 ·Nature ·Charles K. F. Chan, Ching‐Cheng Chen, Cynthia A. Luppen, Jae‐Beom Kim, (unknown), Kevin Wei, Jill A. Helms, Calvin J. Kuo, Daniel Kraft, Irving L. Weissman	322
5	Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways 2007 ·Journal of Molecular Medicine ·Kevin Wei, Frank Kuhnert, Calvin J. Kuo	15
6	A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development breakdown → 2006 ·The Journal of Experimental Medicine ·Jennifer M. Burns, (unknown), Yu Wang, Anita Melikian, (unknown), Zhenhua Miao, Mark E.T. Penfold, Mary Jean Sunshine, Dan R. Littman, Calvin J. Kuo, Kevin Wei, (unknown), K Wright, Maureen Howard, Thomas J. Schall	1048

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact